2002
DOI: 10.1046/j.1523-1747.2002.01814.x
|View full text |Cite
|
Sign up to set email alerts
|

p53 Mutation in Nonmelanoma Skin Cancers Occurring in Psoralen Ultraviolet A-Treated Patients: Evidence for Heterogeneity and Field Cancerization

Abstract: A combination of psoralens and ultraviolet A radiation is widely used to treat psoriasis. Long-term, high-dose exposure to psoralen + ultraviolet A is associated with an increased risk of nonmelanoma skin cancer, particularly squamous cell carcinoma. In this study, we used p53 mutations as a molecular marker to determine the separate contributions of psoralen + ultraviolet A and other ultraviolet exposures, such as ultraviolet B for skin cancer development in psoralen + ultraviolet A-treated psoriasis patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
56
0

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(60 citation statements)
references
References 39 publications
4
56
0
Order By: Relevance
“…We posed the question of whether the presence of telomerase activation was conditioned by lymphocytic infiltration in the tumor margin or in control tissues and whether there was a higher telomerase expression, indicating field cancerization, in the region surrounding the tumor (28)(29)(30)(31). Telomerase activity was identified in activated lymphocytes (60,(84)(85)(86) and in an attendant lymphocytic infiltration (87,88) described in BCC tumor margin (38,87).…”
Section: Comparison Of Htert Results In Basal Cell Carcinomas and Squmentioning
confidence: 99%
See 1 more Smart Citation
“…We posed the question of whether the presence of telomerase activation was conditioned by lymphocytic infiltration in the tumor margin or in control tissues and whether there was a higher telomerase expression, indicating field cancerization, in the region surrounding the tumor (28)(29)(30)(31). Telomerase activity was identified in activated lymphocytes (60,(84)(85)(86) and in an attendant lymphocytic infiltration (87,88) described in BCC tumor margin (38,87).…”
Section: Comparison Of Htert Results In Basal Cell Carcinomas and Squmentioning
confidence: 99%
“…BCCs are characterized by a high rate of loco-regional recurrence and secondary tumors. An important cause of this is field cancerization (28) in the area around the BCC (29)(30)(31)(32). Studies are in progress to find the best suited molecular or immunohistochemical markers for characterizing tumor-free margin tissue (8,12,13,24,(33)(34)(35)(36).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore it seems highly desirable to investigate how the agents described here affect PUVA's therapeutic efficacy using newly available animal models of psoriasis [47][48][49][50][51] and eczema. 52 A better understanding of PUVA's mechanisms may not only offer the opportunity to dissect the beneficial (ie, therapeutic) effects from the detrimental (ie, carcinogenic) side effects 53,54 but also lead to the development of new drugs (eg, using the PAF pathway) acting like PUVA but having less side effects.…”
Section: Discussionmentioning
confidence: 99%
“…Psoralen plus ultraviolet A (UVA) radiation is commonly used to treat a number of dermatologic conditions, but is associated with an increased risk of squamous cell carcinoma, and possibly malignant melanoma [2,3]. Psoralen photoadducts are mutagenic, though their role in cutaneous malignancy is still unclear [4][5][6]. Mechanistically, psoralen intercalates into DNA, and following ultraviolet A (UVA) radiation forms monoadducts with pyrimidine bases initially that with further UVA irradiation may form ICL predominantly at 5â€Č TpA 3â€Č sites [7].…”
Section: Introductionmentioning
confidence: 99%